VivoSeq
Other

Postpartum Period

0

Pipeline Programs↗

1

Active Trials↗

0

Companies Involved↗

Postpartum Period is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

67/100

Attrition Rate

29/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

7

clinical trials

Completed4 · 57%
Recruiting1 · 14%
Withdrawn1 · 14%
Terminated1 · 14%

Clinical Trials

Trial Activity

7 trials

A Randomized, Placebo-controlled Trial of DAPAgliflozin (DAPA) for Cardiovascular Risk Reduction in the Postpartum Period of Hypertensive Pregnancies (HP)
Recruiting·UUniversity of Michigan·Phase 4·NCT06785116·200 enrolled
Paracetamol / Ibuprofen for Postpartum Pain in the Early Postpartum Period
Completed·TTel-Aviv Sourasky Medical Center·N/A·NCT04653506·107 enrolled
Comparing Nifedipine and Enalapril in Medical Resources Used in the Postpartum Period
Completed·—·Phase 4·NCT04236258·94 enrolled
anti10a Levels in Women Treated With LMWH in the Postpartum Period
Completed·HHaEmek Medical Center, Israel·Phase 4·NCT02856295·136 enrolled
HYDEAL-D® Application for Promoting the Restoration of Sexual Function in the Postpartum Period
Completed·OOspedale Policlinico San Martino·Phase 4·NCT04560283·25 enrolled
Pharmacokinetics and Safety of Ertapenem in the Postpartum Period
Terminated·—·Phase 1·NCT01587495·3 enrolled
Intrapartum Epidural Fentanyl and Breastfeeding in the Immediate Postpartum Period: a Randomized, Controlled, Double-blinded Study
Withdrawn·UUniversity Hospitals Cleveland Medical Center·N/A·NCT01497509

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)